Pilot Study of Autologous Anti-EGFRvIII CAR T Cells in Recurrent Glioblastoma Multiforme

NCT02844062 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma Multiforme

Interventions

BIOLOGICAL: anti-EGFRvIII CAR T cells
DRUG: cyclophosphamide
DRUG: Fludarabine

Sponsor

Beijing Sanbo Brain Hospital

Collaborators

[object Object]